← All organizations
Highest phase reached
Phase 2
First clinical trial
Apr 1, 2012Last known activity
Dec 31, 2023
Timeline
2000s
- Jan 1, 2009
Targovax ASA— Founded
Drugs by trial phase (13 distinct, 10 trials)
Phase 2 (11 own, 0 via acquisition)
Phase 1 (2 own, 0 via acquisition)
Indications
Recent trials (11)
- NCT06015724CollaboratorPhase 2Dec 31, 2023
- NCT05841550CollaboratorPhase 1/Phase 2May 19, 2023
- NCT05638698CollaboratorPhase 2Dec 31, 2022
- NCT05561491Lead sponsorPhase 2Dec 31, 2022
- NCT02963831CollaboratorPhase 1/Phase 2Jan 1, 2017
- NCT03003676Lead sponsorPhase 1Dec 1, 2016
- NCT02933944Lead sponsorPhase 1Sep 1, 2016
- NCT02879669Lead sponsorPhase 1/Phase 2Jun 1, 2016
- NCT02261714Lead sponsorPhase 1/Phase 2Dec 1, 2012
- NCT01598129Study directorPhase 1Apr 1, 2012
- NCT01598129Lead sponsorPhase 1Apr 1, 2012
Details
- Founded
- Helsinki, FI Jan 1, 2009
- Last known activity
- Dec 31, 2023
Notes
--- Pre-folding founded info: 2010-06-01 Lysaker None Norway https://www.crunchbase.com/organization/targovax#section-overview ---